期刊文献+

UPLC-MS/MS法同时检测水产品中喹诺酮类药物残留 被引量:13

Simultaneous Determination of Quinolones in Aquatic Products by Ultra Performance Liquid Chromatography-Tandem Mass Spectrometry
原文传递
导出
摘要 利用UPLC-MS/MS技术建立一种同时检测水产品中喹诺酮类药物残留的分析方法。对样品进行前处理及分离条件的优化,样品经柠檬酸磷酸盐缓冲液(Mcllvaine)超声提取,采用固相萃取(SPE)方法净化提取液,并对目标物质进行富集,用UPLC-MS/MS法检测。结果表明:依诺沙星、奥索利酸、培氟沙星、帕珠沙星、氟罗沙星含量在3~300μg/kg范围,萘啶酸、氟甲喹含量在0.5~50μg/kg范围,其余13种喹诺酮类化合物含量在l~100μg/kg范围均具有良好的线性关系,相关系数0.9981~0.9999,定量限(LOQ)0.34~8.13μg/kg。药物含量在5~150μg/kg范围,除氟甲喹、萘啶酸外,其它喹诺酮的回收率均在63.6%~92.8%之间,相对标准偏差1.51%~11.32%。该方法可满足水产品中喹诺酮类药物多残留检测的要求。 An ultra performance liquid chromatography-tandem mass spectrometry(UPLC-MS/MS)method was developed for the trace analysis and validation of 20 quinolones in aquatic products.Pretreatment and isolation conditions of sample were optimized.The analytes were extracted from the samples using Mcllvaine buffer by ultrasonic bath,and purified and enriched by solid-phase extraction(SPE)cartridge,and detected by UPLC-MS/MS.The results showed that the linear range was from 3 μg/kg to 300 μg/kg for enrofloxacin,oxolinic acid,Pefloxacin,Pazufloxacin,Fleroxacin,from0.5 μg/kg to 50 μg/kg for Nalidixic acid,Flimequine,from 1 μg/kg to 100 μg/kg for other 14 QNs with the good correlation coefficients(r≥0.9981).The lower limit of quantification was 0.34 μg/kg to 8.13 μg/kg.The recoveries were 63.6%~92.8%,except for FLU and NAL with relative standard deviations of 1.51%~11.32%,respectively,in spiked tissue samples at concentration levels ranging from 2.5 μg/kg to 150 μg/kg of each quinolone.The method is simple,accurate and sensitive for the simultaneous determination of various QNs in aquatic products.
作者 祝颖 张虹
出处 《中国食品学报》 EI CAS CSCD 北大核心 2010年第2期206-213,共8页 Journal of Chinese Institute Of Food Science and Technology
基金 浙江省科技计划项目(2008C22051)
关键词 喹诺酮类药物 超高效液相-串联质谱法(UPLC-MS/MS) 水产品 quinolones ultra performance liquid chromatography-tandem mass spectrometry aquatic products
  • 相关文献

参考文献25

  • 1Nathwani D, Davey P. Sequential antimierobial therapy the role of quinolones [J]. Antimicrobial Agents and Chemotherapy, 1997,39:441-446.
  • 2刘艳辉,张雅斌,祖岫杰,王拥军.第三代喹喏酮类药物及其在淡水鱼类病害防治中的应用[J].河北渔业,2001(3):11-12. 被引量:6
  • 3李军,黎志强,樊品科.氟喹诺酮类药物对草鱼常见病原菌的体外抑菌试验[J].中国兽药杂志,1999,33(4):25-27. 被引量:11
  • 4Council Regulation 2377/90/EEC concerning the establishment of MRLs in the EU.
  • 5Council Regulation508/99/EEC concerning the establishmenl of MRLs in the EU.
  • 6FDA. FDA announces final decision about veterinary medicine [EB]. [2009-02-12]. http: //www. fda.gov/bbs/topics/news/ 2005 /new 01212. html.
  • 7Hohzapple C K, Buckley S A, Stanker L H. Production and characterization of monoclonal antibodies against sarafioxacin and cross-reactivity studies of related fiuoroquinolones[J]. J. Chromatogr. B.,2001, 754(1): 1-9.
  • 8郑晶,黄晓蓉,李耀平,李小晶,林杰.鳗鱼中恩诺沙星残留量的酶联免疫检测方法[J].食品科学,2004,25(10):247-250. 被引量:41
  • 9Sliverlight J, Coldham N, Thorne L. Antibodies to the quinolones and fluoroquinolones for the development of generic and specific inmunossays for detection of these residues in animal products [J]. Food Addit Contain, 2003, 20(3): 221-228.
  • 10Juhel-Gaugain M, Abjean J P. Screening of quinolone resvidues in pig muscle by planar chromatography[J]. Chrornatographia, 1998, 47:101-104.

二级参考文献78

共引文献288

同被引文献189

引证文献13

二级引证文献101

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部